AllSight
Companies · CBT · Miscellaneous Chemical Products · Exec change · Sep 15, 2026

Cabot names interim CFO as CEO transition leaves finance role open

Interim CFOpartly known
Internal treasurer appointed; permanent CFO search continues
CABOT CORP (CBT) — what happened, in plain English, and what it means versus what the market expected.

Cabot is a global specialty-chemicals and performance-materials company organized around Reinforcement Materials and Performance Chemicals, with growth initiatives tied to specialty carbons, battery materials and other advanced materials. This filing completes the planned leadership handoff but leaves the finance seat unresolved. Erica McLaughlin’s move from CFO to CEO effective October 1 was already disclosed, and the company had already said it was searching for her replacement. The new information is that Steven J. Delahunt, a long-serving internal treasurer, will cover the role temporarily. 〔0〕

The choice favors continuity over a clean succession. Delahunt has been with Cabot since 2010 and previously held investor-relations responsibilities, so the appointment should limit near-term disruption during a broader CEO transition. But an interim CFO also signals that Cabot has not yet solved the permanent leadership gap. 〔1〕

The financial impact is immaterial; the governance signal is the point. The $35,000 monthly stipend is modest relative to the significance of the role, while the absence of disclosed side arrangements or related-party transactions removes an obvious complication. 〔2〕

Bottom line: This is mostly an execution update to a leadership transition the market already knew was coming. It preserves internal continuity, but the still-open permanent CFO search leaves a modest layer of management uncertainty until the role is filled.

Read the original 8-K on SEC EDGAR ↗
More from CABOT CORP (CBT)
Aug 21, 2026Cabot refinances $250M due 2026, extending maturities at a higher 4.95% couponAug 14, 2026Cabot locks in $350M of new debt—without giving investors a payoffAll CBT filings, decoded →
Related companies in Miscellaneous Chemical Products
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact